{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T06:12:07Z","timestamp":1792735927606,"version":"4.5.0"},"reference-count":42,"publisher":"American Medical Association (AMA)","issue":"22","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[2025,6,10]]},"abstract":"<jats:sec id=\"ab-jus250005-1\"><jats:title>Importance<\/jats:title><jats:p>Untreated syphilis infection during pregnancy can be passed to the fetus, causing congenital syphilis. Congenital syphilis is associated with premature birth, low birth weight, stillbirth, neonatal death, and significant abnormalities in the infant such as deformed bones, anemia, enlarged liver and spleen, jaundice, brain and nerve problems (eg, permanent vision or hearing loss), and meningitis. In 2023, there were 3882 cases of congenital syphilis in the US, including 279 congenital syphilis\u2013related stillbirths and neonatal\/infant deaths, the highest number reported in more than 30 years.<\/jats:p><\/jats:sec><jats:sec id=\"ab-jus250005-2\"><jats:title>Objective<\/jats:title><jats:p>The US Preventive Services Task Force (USPSTF) commissioned a reaffirmation evidence update focused on the benefits and harms of screening for syphilis infection in pregnancy.<\/jats:p><\/jats:sec><jats:sec id=\"ab-jus250005-3\"><jats:title>Population<\/jats:title><jats:p>Adolescents and adults who are pregnant.<\/jats:p><\/jats:sec><jats:sec id=\"ab-jus250005-4\"><jats:title>Evidence Assessment<\/jats:title><jats:p>The USPSTF concludes with high certainty that screening for syphilis infection in pregnancy has a substantial net benefit.<\/jats:p><\/jats:sec><jats:sec id=\"ab-jus250005-5\"><jats:title>Recommendation<\/jats:title><jats:p>The USPSTF recommends early, universal screening for syphilis infection during pregnancy; if an individual is not screened early in pregnancy, the USPSTF recommends screening at the first available opportunity. (A recommendation)<\/jats:p><\/jats:sec>","DOI":"10.1001\/jama.2025.5009","type":"journal-article","created":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T15:01:40Z","timestamp":1747148500000},"page":"2006","source":"Crossref","is-referenced-by-count":28,"title":["Screening for Syphilis Infection During Pregnancy"],"prefix":"10.1001","volume":"333","author":[{"name":"US Preventive Services Task Force","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Silverstein","sequence":"additional","affiliation":[{"name":"Brown University, Providence, Rhode Island"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John B.","family":"Wong","sequence":"additional","affiliation":[{"name":"Tufts University School of Medicine, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esa M.","family":"Davis","sequence":"additional","affiliation":[{"name":"University of Maryland School of Medicine, Baltimore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Chelmow","sequence":"additional","affiliation":[{"name":"Virginia Commonwealth University, Richmond"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tumaini Rucker","family":"Coker","sequence":"additional","affiliation":[{"name":"University of Washington, Seattle"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia","family":"Fernandez","sequence":"additional","affiliation":[{"name":"University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ericka","family":"Gibson","sequence":"additional","affiliation":[{"name":"Kaiser Permanente, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos Roberto","family":"Ja\u00e9n","sequence":"additional","affiliation":[{"name":"The University of Texas Health Science Center, San Antonio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Krousel-Wood","sequence":"additional","affiliation":[{"name":"Tulane University, New Orleans, Louisiana"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sei","family":"Lee","sequence":"additional","affiliation":[{"name":"University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanda K.","family":"Nicholson","sequence":"additional","affiliation":[{"name":"George Washington University, Washington, DC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Goutham","family":"Rao","sequence":"additional","affiliation":[{"name":"Case Western Reserve University, Cleveland, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M.","family":"Ruiz","sequence":"additional","affiliation":[{"name":"University of Arizona, Tucson"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Stevermer","sequence":"additional","affiliation":[{"name":"University of Missouri, Columbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel","family":"Tsevat","sequence":"additional","affiliation":[{"name":"The University of Texas Health Science Center, San Antonio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra Millon","family":"Underwood","sequence":"additional","affiliation":[{"name":"University of Wisconsin, Milwaukee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Wiehe","sequence":"additional","affiliation":[{"name":"Indiana University, Bloomington"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"46","key":"jus250005r4","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.15585\/mmwr.mm7246e1","article-title":"Vital Signs: missed opportunities for preventing congenital syphilis\u2014United States, 2022.","volume":"72","author":"McDonald","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"jus250005r6","doi-asserted-by":"publisher","first-page":"S115","DOI":"10.1086\/425280","article-title":"Social context, sexual networks, and racial disparities in rates of sexually transmitted infections.","volume":"191","author":"Adimora","year":"2005","journal-title":"J Infect Dis"},{"issue":"8","key":"jus250005r7","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1016\/S0277-9536(99)00197-5","article-title":"Things ain\u2019t what they ought to be: social forces underlying racial disparities in rates of sexually transmitted diseases in a rural North Carolina county.","volume":"49","author":"Thomas","year":"1999","journal-title":"Soc Sci Med"},{"issue":"12","key":"jus250005r8","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.1097\/OLQ.0b013e31818d3cad","article-title":"Social determinants and sexually transmitted disease disparities.","volume":"35","author":"Hogben","year":"2008","journal-title":"Sex Transm Dis"},{"issue":"9","key":"jus250005r9","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1001\/jama.2018.11785","article-title":"Screening for syphilis infection in pregnant women: US Preventive Services Task Force reaffirmation recommendation statement.","volume":"320","author":"US Preventive Services Task Force","year":"2018","journal-title":"JAMA"},{"issue":"1","key":"jus250005r11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr7301a1","article-title":"CDC laboratory recommendations for syphilis testing, United States, 2024.","volume":"73","author":"Papp","year":"2024","journal-title":"MMWR Recomm Rep"},{"issue":"39","key":"jus250005r13","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.15585\/mmwr.mm6739a3","article-title":"Factors contributing to congenital syphilis cases\u2014New York City, 2010-2016.","volume":"67","author":"Slutsker","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1","key":"jus250005r14","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1177\/0033354920967350","article-title":"Using surveillance data to respond to an outbreak of congenital syphilis in Arizona through third-trimester screening policies, 2017-2018.","volume":"136","author":"Sykes","year":"2021","journal-title":"Public Health Rep"},{"issue":"8","key":"jus250005r15","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1097\/OLQ.0000000000000638","article-title":"Effectiveness of prenatal screening and treatment to prevent congenital syphilis, Louisiana and Florida, 2013-2014.","volume":"44","author":"Matthias","year":"2017","journal-title":"Sex Transm Dis"},{"issue":"4","key":"jus250005r16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr7004a1","article-title":"Sexually transmitted infections treatment guidelines, 2021.","volume":"70","author":"Workowski","year":"2021","journal-title":"MMWR Recomm Rep"},{"issue":"4","key":"jus250005r22","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.anai.2010.08.002","article-title":"Drug allergy: an updated practice parameter.","volume":"105","author":"Joint Task Force on Practice Parameters","year":"2010","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"12","key":"jus250005r23","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1001\/jama.2022.15322","article-title":"Screening for syphilis infection in nonpregnant adolescents and adults: US Preventive Services Task Force reaffirmation recommendation statement.","volume":"328","author":"US Preventive Services Task Force","year":"2022","journal-title":"JAMA"},{"issue":"10","key":"jus250005r24","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1001\/jama.2021.14081","article-title":"Screening for chlamydia and gonorrhea: US Preventive Services Task Force recommendation statement.","volume":"326","author":"US Preventive Services Task Force","year":"2021","journal-title":"JAMA"},{"issue":"4","key":"jus250005r25","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1001\/jama.2019.9365","article-title":"Screening for hepatitis B virus infection in pregnant women: US Preventive Services Task Force reaffirmation recommendation statement.","volume":"322","author":"US Preventive Services Task Force","year":"2019","journal-title":"JAMA"},{"issue":"23","key":"jus250005r26","doi-asserted-by":"publisher","first-page":"2415","DOI":"10.1001\/jama.2020.22980","article-title":"Screening for hepatitis B virus infection in adolescents and adults: US Preventive Services Task Force recommendation statement.","volume":"324","author":"US Preventive Services Task Force","year":"2020","journal-title":"JAMA"},{"issue":"6","key":"jus250005r27","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1001\/jama.2023.0057","article-title":"Serologic screening for genital herpes infection: US Preventive Services Task Force reaffirmation recommendation statement.","volume":"329","author":"US Preventive Services Task Force","year":"2023","journal-title":"JAMA"},{"issue":"23","key":"jus250005r28","doi-asserted-by":"publisher","first-page":"2326","DOI":"10.1001\/jama.2019.6587","article-title":"Screening for HIV infection: US Preventive Services Task Force recommendation statement.","volume":"321","author":"US Preventive Services Task Force","year":"2019","journal-title":"JAMA"},{"issue":"7","key":"jus250005r29","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1001\/jama.2020.13095","article-title":"Behavioral counseling interventions to prevent sexually transmitted infections: US Preventive Services Task Force recommendation statement.","volume":"324","author":"US Preventive Services Task Force","year":"2020","journal-title":"JAMA"},{"key":"jus250005r30","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2025.1179","article-title":"Screening for syphilis infection during pregnancy: updated evidence report and systematic review for the US Preventive Services Task Force.","author":"Asher","year":"2025","journal-title":"JAMA"},{"issue":"7","key":"jus250005r32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0102203","article-title":"Reported estimates of adverse pregnancy outcomes among women with and without syphilis: a systematic review and meta-analysis.","volume":"9","author":"Qin","year":"2014","journal-title":"PLoS One"},{"issue":"12","key":"jus250005r33","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1007\/s10096-014-2186-8","article-title":"Synthesized prevention and control of one decade for mother-to-child transmission of syphilis and determinants associated with congenital syphilis and adverse pregnancy outcomes in Shenzhen, South China.","volume":"33","author":"Qin","year":"2014","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"1","key":"jus250005r34","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1055\/s-0039-3400994","article-title":"Abbott ARCHITECT syphilis TP chemiluminescent immunoassay accurately diagnoses past or current syphilis in pregnancy.","volume":"37","author":"Adhikari","year":"2020","journal-title":"Am J Perinatol"},{"issue":"7","key":"jus250005r35","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1038\/s41372-019-0387-9","article-title":"Evaluating congenital syphilis in a reverse sequence testing environment.","volume":"39","author":"Chen","year":"2019","journal-title":"J Perinatol"},{"key":"jus250005r36","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jpeds.2019.11.035","article-title":"Reverse sequence syphilis screening and discordant results in pregnancy.","volume":"219","author":"Williams","year":"2020","journal-title":"J Pediatr"},{"issue":"7","key":"jus250005r37","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1055\/s-0039-3402748","article-title":"Syphilis immunoassay signal strength correlates with active infection in pregnant women.","volume":"37","author":"Zofkie","year":"2020","journal-title":"Am J Perinatol"},{"issue":"1","key":"jus250005r38","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1373\/jalm.2017.024943","article-title":"Evaluation of the Elecsys syphilis immunoassay for detection of syphilis in populations at risk of disease in the US and Argentina.","volume":"3","author":"Christenson","year":"2018","journal-title":"J Appl Lab Med"},{"issue":"10","key":"jus250005r40","doi-asserted-by":"publisher","first-page":"e107","DOI":"10.1097\/OLQ.0000000000001610","article-title":"Retrospective cohort study of the incidence and outcomes of Jarisch-Herxheimer reactions after treatment of infectious syphilis in late pregnancy.","volume":"49","author":"Macumber","year":"2022","journal-title":"Sex Transm Dis"},{"issue":"6","key":"jus250005r41","doi-asserted-by":"publisher","DOI":"10.1016\/j.waojou.2021.100549","article-title":"Algorithm to guide re-exposure to penicillin in allergic pregnant women with syphilis: efficacy and safety.","volume":"14","author":"Garcia","year":"2021","journal-title":"World Allergy Organ J"},{"key":"jus250005r1","author":"Asher","year":"2025"},{"key":"jus250005r18","volume-title":"Guidelines for Perinatal Care","author":"AAP Committee on the Fetus and Newborn and ACOG Committee on Obstetric Practice","year":"2017","edition":"8th ed"},{"key":"jus250005r31","author":"Lin","year":"2018"},{"key":"jus250005r2","unstructured":"Centers for Disease Control and Prevention. National overview of STIs in 2023. Published November 12, 2024. Accessed March 17, 2025. https:\/\/www.cdc.gov\/sti-statistics\/annual\/summary.html"},{"key":"jus250005r3","unstructured":"Centers for Disease Control and Prevention. Sexually transmitted disease surveillance 2021. Published July 2021. Accessed March 17, 2025. https:\/\/www.cdc.gov\/sti-statistics\/media\/pdfs\/2024\/07\/2021-STD-Surveillance-Report-PDF_ARCHIVED-2-16-24.pdf"},{"key":"jus250005r5","unstructured":"Centers for Disease Control and Prevention. Sexually transmitted infections surveillance 2023: congenital syphilis. Accessed March 17, 2025. https:\/\/www.cdc.gov\/sti-statistics\/annual\/slides.html"},{"key":"jus250005r10","unstructured":"US Preventive Services Task Force. US Preventive Services Task Force Procedure Manual. Published May 2021. Accessed March 17, 2025. https:\/\/www.uspreventiveservicestaskforce.org\/uspstf\/about-uspstf\/methods-and-processes\/procedure-manual"},{"key":"jus250005r12","unstructured":"US Food and Drug Administration. FDA marketing authorization enables increased access to first step of syphilis diagnosis. Published August 16, 2024. Accessed March 17, 2025. https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-marketing-authorization-enables-increased-access-first-step-syphilis-diagnosis"},{"key":"jus250005r17","unstructured":"Women\u2019s Preventive Services Initiative. Recommendations for well-woman care: 2024 clinical summary tables. Accessed March 17, 2025. https:\/\/www.womenspreventivehealth.org\/wp-content\/uploads\/FINAL-WPSI-Clinical-Summary-Tables-2024.pdf"},{"key":"jus250005r19","unstructured":"American College of Obstetricians and Gynecologists. Practice advisory: screening for syphilis in pregnancy. Published April 2024. Accessed March 17, 2025. https:\/\/www.acog.org\/clinical\/clinical-guidance\/practice-advisory\/articles\/2024\/04\/screening-for-syphilis-in-pregnancy"},{"key":"jus250005r20","unstructured":"Centers for Disease Control and Prevention. State statutory and regulatory language regarding prenatal syphilis screenings in the United States. Published July 25, 2024. Accessed March 17, 2025. https:\/\/www.cdc.gov\/syphilis\/media\/pdfs\/2024\/07\/Prenatal-Syphilis-Screening-Laws-Web-Document-25-July-2024-final.pdf"},{"key":"jus250005r21","unstructured":"Centers for Disease Control and Prevention. Clinical features of penicillin allergy. Accessed March 17, 2025. https:\/\/www.cdc.gov\/antibiotic-use\/hcp\/clinical-signs\/index.html"},{"key":"jus250005r39","unstructured":"Dhakal? A, Sbar? E. Jarisch-Herxheimer reaction. Updated April 24, 2023. Accessed March 17, 2025. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK557820\/"},{"key":"jus250005r42","unstructured":"American Academy of Family Physicians. Clinical preventive service recommendation: syphilis. Accessed October 24, 2024. https:\/\/www.aafp.org\/family-physician\/patient-care\/clinical-recommendations\/all-clinical-recommendations\/syphilis.html"}],"container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/articlepdf\/2833883\/jama_silverstein_2025_us_250005_1748540673.10853.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T15:00:31Z","timestamp":1749567631000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2833883"}},"subtitle":["US Preventive Services Task Force Reaffirmation Recommendation Statement"],"short-title":[],"issued":{"date-parts":[[2025,6,10]]},"references-count":42,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2025,6,10]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.2025.5009","relation":{},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6,10]]}}}